Direkt zum Inhalt
Merck
Alle Fotos(1)

Key Documents

View All Documentation

1287030

USP

Furosemid-verwandte Verbindung B

United States Pharmacopeia (USP) Reference Standard

Synonym(e):

4-Chlor-5-Sulfamoylanthranilsäure

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C7H7ClN2O4S
CAS-Nummer:
3086-91-7
Molekulargewicht:
250.66
MDL-Nummer:
MFCD03423689
UNSPSC-Code:
41116107
PubChem Substanz-ID:
329749918
NACRES:
NA.24

Qualität

pharmaceutical primary standard

API-Familie

furosemide

Hersteller/Markenname

USP

mp (Schmelzpunkt)

267 °C (dec.) (lit.)

Anwendung(en)

pharmaceutical (small molecule)

Format

neat

SMILES String

Nc1cc(Cl)c(cc1C(O)=O)S(N)(=O)=O

InChI

1S/C7H7ClN2O4S/c8-4-2-5(9)3(7(11)12)1-6(4)15(10,13)14/h1-2H,9H2,(H,11,12)(H2,10,13,14)

InChIKey

QQLJBZFXGDHSRU-UHFFFAOYSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Furosemide Related Compound B USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.

Hinweis zur Analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Sonstige Hinweise

Sales restrictions may apply.

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

F0700000

Furosemid, European Pharmacopoeia (EP) Reference Standard

1287008

Furosemid, United States Pharmacopeia (USP) Reference Standard

F0702000

Furosemid-Unreinheit A, European Pharmacopoeia (EP) Reference Standard

1287020

Furosemid-verwandte Verbindung A, United States Pharmacopeia (USP) Reference Standard

PHR1057

Furosemid, Pharmaceutical Secondary Standard; Certified Reference Material

Y0001493

Furosemid für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard

BP547

Furosemid, British Pharmacopoeia (BP) Reference Standard

BP074

4-Chlor-5-Sulfamoylanthranilsäure, British Pharmacopoeia (BP) Reference Standard

PHR2457

2,4-Dichlorbenzilsäure, Pharmaceutical Secondary Standard; Certified Reference Material

Piktogramme

Environment
GHS09

H-Sätze

H411

P-Sätze

P273

Gefahreneinstufungen

Aquatic Chronic 2

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

[Determination of furosemide and its metabolic products in plasma and urine by high performance liquid chromatography and clinical application].
Y Miwa et al.
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 108(11), 1087-1092 (1988-11-01)
D E Smith et al.
Drug metabolism and disposition: the biological fate of chemicals, 8(5), 337-342 (1980-09-01)
The objectives of this study were to qualitatively and quantitatively compare the metabolism, pharmacokinetics, and bioavailability of furosemide in healthy volunteers after intravenous and oral administration. We also determined the plasma protein binding of furosemide in vivo after iv administration.
G M Hanna et al.
Journal of AOAC International, 76(3), 526-530 (1993-05-01)
A simple, specific, and accurate proton nuclear magnetic resonance (1H-NMR) spectroscopic method has been developed for the identification and assay of furosemide and its degradation product, 4-chloro-5-sulfamoylanthranilic acid (CSA), in tablets and injections. Dissolution of the sample in D2O-NaOD resulted
H Nakahama et al.
European journal of clinical pharmacology, 32(3), 313-315 (1987-01-01)
Urine from 5 renal transplant recipients treated with frusemide was analyzed for unchanged frusemide (F), glucuronidated frusemide (G) and 4-chloro-5-sulfamoylanthranilic acid (CSA) by HPLC. In 3 recipients, whose renal function recovered steadily and whose hepatic function was normal throughout, the
L Z Benet et al.
Federation proceedings, 42(6), 1695-1698 (1983-04-01)
A variety of furosemide assays and their application to biological samples have been described over the past 2 decades. We describe development of a specific, sensitive assay appropriate for efficient measurement of large numbers of biological samples. With development of
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.